RALEIGH, N.C.--(BUSINESS WIRE)--American Clinical Research Services (ACRS), a leader in complex clinical research, is proud to announce its rebranding to Elixia, signifying the company’s expanded vision and capabilities in the clinical research and patient recruitment sectors. Elixia is a portfolio company of Latticework Capital Management..

北卡罗来纳州罗利市——（商业新闻短讯）——美国临床研究服务公司（ACRS）是复杂临床研究领域的领导者，它自豪地宣布将更名为Elixia，这标志着该公司在临床研究和患者招募领域的愿景和能力得到了扩展。Elixia是一家晶格资本管理的投资组合公司。。

This transition to Elixia signifies more than a name change, embodying the company’s commitment to drug development and healthcare delivery. Elixia combines the robust capabilities of premier clinical research sites with a leading patient recruitment engine, enabling it to support clinical trials with efficiency and precision.

向Elixia的转变不仅仅意味着名称的改变，体现了该公司对药物开发和医疗保健服务的承诺。Elixia将卓越临床研究网站的强大功能与领先的患者招募引擎相结合，使其能够高效准确地支持临床试验。

The name Elixia was chosen to capture the essence of the company’s mission: to accelerate the development of life-changing therapies and improve patient outcomes worldwide..

选择Elixia这个名字是为了抓住公司使命的本质：加速发展改变生活的疗法，改善全球患者的预后。。

“Rebranding to Elixia represents the unification of our diverse strengths under a shared vision,” said Dustin Owen, CEO of Elixia. “Our integrated approach and expanded reach uniquely position us to address the complexities of modern drug development. With Elixia, we are poised to make a profound impact on the healthcare landscape, driving innovations that bring new treatments to patients faster and more effectively than ever before.”.

Elixia首席执行官达斯汀·欧文（DustinOwen）表示：“更名为Elixia代表了我们在共同愿景下的多种优势的统一。”。“我们的综合方法和扩大的覆盖范围使我们能够独特地解决现代药物开发的复杂性。凭借Elixia，我们将对医疗保健领域产生深远的影响，推动创新，为患者带来比以往任何时候都更快、更有效的新疗法。”。

Established in 2022 through the acquisition of Catalina Research Institute, a leader in therapeutically focused clinical research, ACRS has positioned itself as a significant player in the industry. Building on this foundation, ACRS strengthened its services in 2023, acquiring CSSi and Patient Advertising Guru, both prominent companies specializing in patient recruitment.

ACRS成立于2022年，通过收购专注于治疗的临床研究的领导者Catalina Research Institute，已将自己定位为该行业的重要参与者。在此基础上，ACRS于2023年加强了服务，收购了CSSi和Patient Advertising Guru，这两家公司都是专门从事患者招聘的知名公司。

The culmination of these strategic acquisitions is the recent addition of Elixia, whose name will now be adopted for the entire organization. The company remains committed to its partners, patients and stakeholders as it embarks on this exciting new chapter..

这些战略收购的高潮是最近增加了Elixia，其名称现在将被整个组织采用。当公司开始这一激动人心的新篇章时，它仍然致力于其合作伙伴、患者和利益相关者。。

About Elixia

关于艾莉霞

Elixia is an industry-leading clinical research entity, linking a vast network of multi-site clinical research facilities with a global patient recruitment operation. With sites in California, Florida, Massachusetts, Missouri, Michigan, and Texas, Elixia conducts Phase I-IV studies, addressing complex conditions in metabolic health, nephrology, neuroscience, and infectious diseases.

Elixia是一家行业领先的临床研究实体，将多站点临床研究设施的庞大网络与全球患者招募业务联系起来。Elixia在加利福尼亚州、佛罗里达州、马萨诸塞州、密苏里州、密歇根州和德克萨斯州开展了I-IV期研究，以解决代谢健康、肾脏病、神经科学和传染病等复杂疾病。

Elixia is renowned globally for its technological prowess, which enhances efficiency in patient acquisition and offers critical health outcome data that provides invaluable insights to sponsors worldwide. For more information, please visit elixiahealth.com..

Elixia以其技术实力而闻名全球，它提高了患者获取的效率，并提供了关键的健康结果数据，为全球赞助商提供了宝贵的见解。有关更多信息，请访问elixiahealth.com。。

About Latticework Capital Management (LCM)

关于晶格资本管理（LCM）

Headquartered in Dallas, TX, Latticework is a growth oriented private equity firm focused exclusively on making control equity investments in the healthcare industry. LCM has completed more than 130 transactions across a diverse array of healthcare subsectors and currently has more than $550 million in assets under management.

Latticework总部位于德克萨斯州达拉斯，是一家以增长为导向的私人股本公司，专注于在医疗保健行业进行控制股权投资。LCM已经完成了130多项医疗保健子部门的交易，目前管理的资产超过5.5亿美元。

LCM leverages its more than 100 combined years of healthcare and investing experience, as well as its network of industry executives, to help companies scale and realize their full long-term value. For more information, please visit latticeworkcapital.com..

LCM利用其100多年的医疗保健和投资经验，以及其行业高管网络，帮助公司扩大规模并实现其全部长期价值。有关更多信息，请访问latticeworkcapital.com。。